105 related articles for article (PubMed ID: 32326970)
21. NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma.
Neri L; Lasa M; Elosegui-Artola A; D'Avola D; Carte B; Gazquez C; Alve S; Roca-Cusachs P; Iñarrairaegui M; Herrero J; Prieto J; Sangro B; Aldabe R
Oncotarget; 2017 Jun; 8(25):40967-40981. PubMed ID: 28498797
[TBL] [Abstract][Full Text] [Related]
22. NHE7 upregulation potentiates the uptake of small extracellular vesicles by enhancing maturation of macropinosomes in hepatocellular carcinoma.
Yao Y; Xu Y; Yu L; Xue TM; Xiao ZJ; Tin PC; Fung HL; Ma HT; Yun JP; Yam JWP
Cancer Commun (Lond); 2024 Feb; 44(2):251-272. PubMed ID: 38152992
[TBL] [Abstract][Full Text] [Related]
23. LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells.
Liu X; Xiong F; Wei X; Yang H; Zhou R
Cancer Sci; 2009 Dec; 100(12):2335-40. PubMed ID: 19843073
[TBL] [Abstract][Full Text] [Related]
24. IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling.
Min J; Feng Q; Liao W; Liang Y; Gong C; Li E; He W; Yuan R; Wu L
FEBS Open Bio; 2018 Aug; 8(8):1299-1311. PubMed ID: 30087833
[TBL] [Abstract][Full Text] [Related]
25. Micromorphological observation of HLE cells under knockdown of Fascin using LV-SEM.
Hayashi Y; Yamamoto Y; Murakami I
Med Mol Morphol; 2023 Dec; 56(4):257-265. PubMed ID: 37526656
[TBL] [Abstract][Full Text] [Related]
26. Heat shock protein family A member 8 serving as a co-activator of transcriptional factor ETV4 up-regulates PHLDA2 to promote the growth of liver cancer.
Wang S; Wang YF; Yang G; Zhang HH; Yuan HF; Hou CY; Zhao LN; Suo YH; Sun J; Sun LL; Lv P; Sun Y; Zhang NN; Zhang XD; Lu W
Acta Pharmacol Sin; 2023 Dec; 44(12):2525-2536. PubMed ID: 37474643
[TBL] [Abstract][Full Text] [Related]
27. A Regulator Role for the ATP-Binding Cassette Subfamily C Member 6 Transporter in HepG2 Cells: Effect on the Dynamics of Cell-Cell and Cell-Matrix Interactions.
Matera I; Miglionico R; Abruzzese V; Marchese G; Ventola GM; Castiglione Morelli MA; Bisaccia F; Ostuni A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003580
[TBL] [Abstract][Full Text] [Related]
28. Nucleus-localized circSLC39A5 suppresses hepatocellular carcinoma development by binding to STAT1 to regulate TDG transcription.
Liu M; Lai M; Li D; Zhang R; Wang L; Peng W; Yang J; He W; Sheng Y; Xiao S; Nan A; Zeng X
Cancer Sci; 2023 Oct; 114(10):3884-3899. PubMed ID: 37549641
[TBL] [Abstract][Full Text] [Related]
29. Corrigendum to "CRKL knockdown promotes in vitro proliferation, migration and invasion, in vivo tumor malignancy and lymph node metastasis of murine hepatocarcinoma Hca-P cells" [Biomed. Pharmacother. 71 (2015) 84-90].
Shi J; Meng L; Sun MZ; Guo C; Sun X; Lin Q; Liu S
Biomed Pharmacother; 2023 Dec; 168():115662. PubMed ID: 37858416
[No Abstract] [Full Text] [Related]
30. The E-Twenty-Six Family in Hepatocellular Carcinoma: Moving into the Spotlight.
Zhang T; Liu D; Wang Y; Sun M; Xia L
Front Oncol; 2020; 10():620352. PubMed ID: 33585247
[TBL] [Abstract][Full Text] [Related]
31. miR-429-CRKL axis regulates clear cell renal cell carcinoma malignant progression through SOS1/MEK/ERK/MMP2/MMP9 pathway.
Wang J; Wang C; Li Q; Guo C; Sun W; Zhao D; Jiang S; Hao L; Tian Y; Liu S; Sun MZ
Biomed Pharmacother; 2020 Jul; 127():110215. PubMed ID: 32413671
[TBL] [Abstract][Full Text] [Related]
32. miR-124-3p Suppresses the Invasiveness and Metastasis of Hepatocarcinoma Cells
Majid A; Wang J; Nawaz M; Abdul S; Ayesha M; Guo C; Liu Q; Liu S; Sun MZ
Front Mol Biosci; 2020; 7():223. PubMed ID: 33094104
[TBL] [Abstract][Full Text] [Related]
33. Correction to: A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.
Guo C; Gao C; Zhao D; Li J; Wang J; Sun X; Liu Q; Hao L; Greenaway FT; Tian Y; Liu S; Sun MZ
J Exp Clin Cancer Res; 2021 Feb; 40(1):68. PubMed ID: 33596951
[No Abstract] [Full Text] [Related]
34. Crk and CrkL as Therapeutic Targets for Cancer Treatment.
Park T
Cells; 2021 Mar; 10(4):. PubMed ID: 33801580
[TBL] [Abstract][Full Text] [Related]
35. CRKL promotes hepatocarcinoma through enhancing glucose metabolism of cancer cells via activating PI3K/Akt.
Guo C; Gao C; Lv X; Zhao D; Greenaway FT; Hao L; Tian Y; Liu S; Sun MZ
J Cell Mol Med; 2021 Mar; 25(5):2714-2724. PubMed ID: 33523562
[TBL] [Abstract][Full Text] [Related]
36. miRNA-200c-3p deficiency promotes epithelial-mesenchymal transition in triple-negative breast cancer by activating CRKL expression.
Nie F; Zhang Q; Ma W; Yan J
Discov Oncol; 2024 May; 15(1):146. PubMed ID: 38717531
[TBL] [Abstract][Full Text] [Related]
37. CRKL but not CRKII contributes to hemin-induced erythroid differentiation of CML.
Guo C; Lv X; Zhang Q; Yi L; Ren Y; Li Z; Yan J; Zheng S; Sun MZ; Liu S
J Cell Mol Med; 2024 May; 28(9):e18308. PubMed ID: 38683131
[TBL] [Abstract][Full Text] [Related]
38. USP53 Exerts Tumor-Promoting Effects in Triple-Negative Breast Cancer by Deubiquitinating CRKL.
Liu Y; Tang W; Yao F
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894400
[TBL] [Abstract][Full Text] [Related]
39. SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma.
Hu Q; Liu Q; Zhao Y; Zhang L; Li L
Biomark Res; 2022 Nov; 10(1):82. PubMed ID: 36380369
[TBL] [Abstract][Full Text] [Related]
40. The mechanism of the Nfe2l2/Hmox1 signaling pathway in ferroptosis regulation in acute compartment syndrome.
Zheng T; Huang Z; Ling H; Li J; Cheng H; Chen D; Lu Q; Zhao J; Su W
J Biochem Mol Toxicol; 2023 Jan; 37(1):e23228. PubMed ID: 36193742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
